Accelerated fracture healing in mice lacking the 5-lipoxygenase gene

Acta Orthopaedica

Volumn 81, Issue 6, 2010, Pages 748-755

  Manigrasso, Michaele B ^a   O'Connor, J Patrick ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; LEUKOTRIENE B4; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA;

ACCELERATED FRACTURE HEALING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARACHIDONIC ACID METABOLISM; ARTICLE; BONE RADIOGRAPHY; CALLUS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMUR FRACTURE; FRACTURE HEALING; GENE MUTATION; HISTOLOGY; MECHANICAL TORSION; MORPHOMETRICS; MOUSE; NONHUMAN;

ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; BONY CALLUS; CYCLOOXYGENASE 2; FEMORAL FRACTURES; FRACTURE HEALING; HUMANS; LEUKOTRIENES; MICE; MICE, INBRED C57BL; MUTATION; TENSILE STRENGTH;

EID: 78649683923     PISSN: 17453674     EISSN: 17453682     Source Type: Journal    
DOI: 10.3109/17453674.2010.533931     Document Type: Article

References (48)

1. Baron R, Vigney A, Neff L, Silvergate A, Santa Maria A. Processing of unde-calcifed bone specimens for bone histomorphometry. In: Bone histomor-phometry: Techniques and hnterpretation. (Ed Recker RR). Boca Raton: CRC Press, Inc.; 1983: 13-35.
2. Bonewald LF, Flynn M, Qiao M, Dallas M R, Mundy G R, Boyce B F. Mice lacking 5-lipoxygenase have increased cortical bone thickness. Adv Exp Med Biol 1997; 433: 299-302.
3. Burd T A, Hughes M S, Anglen J O. Heterotopic ossifcation prophylaxis with indomethacin increases the risk of long-bone nonunion. J Bone Joint Surg (Br) 2003; 85: 700-5.
4. Byrum R S, Goulet J L, Griffths R J, Koller B H. Role of the 5-lipoxygenase-activating protein (FLAP) in murine acute infammatory responses. J Exp Med 1997; 185: 1065-75.
5. Capper E A, Marshall L A. Mammalian phospholipases A(2): mediators of infammation, proliferation and apoptosis. Prog Lipid Res 2001; 40: 167-97.
6. Chan C-C, Boyce S, Brideau C, Charleson S, Cromlish W, Ethier D, et al. Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone] : a potent and orally active cyclooxygenase-2 inhibitor Pharmacological and biochemical profles. J Pharmacol Exp Ther 1999; 290: 551-60.
7. Chen X S, Sheller J R, Johnson E N, Funk C D. Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene. Nature 1994; 372: 179-82.
8. Clark C A, Schwarz E M, Zhang X, Ziran N M, Drissi H, O'Keefe R J, et al. Differential regulation of EP receptor isoforms during chondrogenesis and chondrocyte maturation. Biochem Biophys Res Commun 2005; 328: 764-76.
9. Cottrell J A, O'Connor J P. Pharmacological inhibition of 5-lipoxygenase accelerates and enhances fracture-healing. J Bone Joint Surg (Am) 2009; 91: 2653-65.
10. Cottrell J A, Meyenhofer M, Medicherla S, Higgins L, O'Connor J P. Analge-sic effects of p38 kinase inhibitor treatment on bone fracture healing. Pain 2009; 142: 116-26.
11. Dabrowski S, Kur J. Cloning and expression in Escherichia coli of the recom-binant his-tagged DNA polymerases from Pyrococcus furiosus and Pyro-coccus woesei. Protein Expr Purif 1998; 14: 131-8.
12. Flynn M A, Qiao M, Garcia C, Dallas M, Bonewald L F Avian osteoclast cells are stimulated to resorb calcifed matrices by and possess receptors for leukotriene B4. Calcif Tissue Int 1999; 64: 154-9.
13. Form D M, Auerbach R. PGE2 and angiogenesis. Proc Soc Exp Biol Med 1983; 172: 214-8.
14. Gallwitz W E, Mundy G R, Lee C H, Qiao M, Roodman G D, Raftery M, et al. 5-Lipoxygenase metabolites of arachidonic acid stimulate isolated osteoclasts to resorb calcifed matrices. J Biol Chem 1993; 268: 10087-94.
15. Garcia C, Boyce B F, Gilles J, Dallas M, Qiao M, Mundy G R, et al. Leukot-riene B4 stimulates osteoclastic bone resorption both in vitro and in vivo. J Bone Miner Res 1996; 11: 1619-27.
16. Hudson N, Balsitis M, Everitt S, Hawkey C J. Enhanced gastric mucosal leu-kotriene B4 synthesis in patients taking non-steroidal anti-infammatory drugs. Gut 1993; 34: 742-7.
17. Jakob M, Demarteau O, Suetterlin R, Heberer M, Martin I. Chondrogenesis of expanded adult human articular chondrocytes is enhanced by specifc prostaglandins. Rheumatology (Oxford) 2004; 43: 852-7.
18. Kennedy B P, Payette P, Mudgett J, Vadas P, Pruzanski W, Kwan M, et al. A natural disruption of the secretory group II phospholipase A2 gene in inbred mouse strains. J Biol Chem 1995; 270: 22378-85.
19. Langenbach R, Morham S G, Tiano H F, Loftin C D, Ghanayem B I, Chu-lada P C, et al. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced infammation and indomethacin-induced gastric ulceration. Cell 1995; 83: 483-92.
20. Li M, Ke H Z, Qi H, Healy D R, Li Y, Crawford D T, et al. A novel, non-pros-tanoid EP2 receptor-selective prostaglandin E2 agonist stimulates local bone formation and enhances fracture healing. J Bone Miner Res 2003; 18: 2033-42.
21. Li M, Healy D R, Li Y, Simmons H A, Crawford D T, Ke H Z, et al. Osteo-penia and impaired fracture healing in aged EP4 receptor knockout mice. Bone 2005; 37: 46-54.
22. Lowe G N, Fu Y H, McDougall S, Polendo R, Williams A, Benya P D, et al. Effects of prostaglandins on deoxyribonucleic acid and aggrecan synthe-sis in the RCJ 3.1C5.18 chondrocyte cell line: role of second messengers. Endocrinology 1996; 137: 2208-16.
23. Maniatopoulos C, Rodriguez A, Deporter D A, Melcher A H. An improved method for preparing histological sections of metallic implants. Int J Oral Maxillofac Implants 1986; 1: 31-7.
24. Manigrasso M B, O'Connor J P. Characterization of a closed femur fracture model in mice. J Orthop Trauma 2004; 18: 687-95.
25. Manigrasso M B, O'Connor J P. Comparison of fracture healing among dif-ferent inbred mouse strains. Calcif Tissue Int 2008; 82: 465-74.
26. Marcouiller P, Pelletier J P, Guevremont M, Martel-Pelletier J, Ranger P, Laufer S, et al. Leukotriene and prostaglandin synthesis pathways in osteo-arthritic synovial membranes: regulating factors for interleukin 1beta syn-thesis. J Rheumatol 2005; 32: 704-12.
27. Martel-Pelletier J, Mineau F, Fahmi H, Laufer S, Reboul P, Boileau C, et al. Regulation of the expression of 5-lipoxygenase-activating protein/5-lipoxygenase and the synthesis of leukotriene B(4) in osteoarthritic chon-drocytes: role of transforming growth factor beta and eicosanoids. Arthritis Rheum 2004; 50: 3925-33.
28. Maxis K, Delalandre A, Martel-Pelletier J, Pelletier J P, Duval N, Lajeunesse D. The shunt from the cyclooxygenase to lipoxygenase pathway in human osteoarthritic subchondral osteoblasts is linked with a variable expression of the 5-lipoxygenase-activating protein. Arthritis Res Ther 2006; 8: R181.
29. Morham S G, Langenbach R, Loftin C D, Tiano H F, Vouloumanos N, Jen-nette J C, et al. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 1995; 83: 473-82.
30. Mountziaris P M, Mikos A G. Modulation of the infammatory response for enhanced bone tissue regeneration. Tissue Eng Part B Rev 2008; 14: 179-86.
31. Murphy R C, Gijon M A. Biosynthesis and metabolism of leukotrienes. Bio-chem J 2007; 405: 379-95
32. Paralkar V M, Borovecki F, Ke H Z, Cameron K O, Lefker B, Grasser W A, et al. An EP2 receptor-selective prostaglandin E2 agonist induces bone heal-ing. Proc Natl Acad Sci USA 2003; 100: 6736-40.
33. Raisz L G. Prostaglandins and bone: physiology and pathophysiology. Osteoarthritis Cartilage 1999; 7: 419-21.
34. Ren W, Dziak R. Effects of leukotrienes on osteoblastic cell proliferation. Calcif Tissue Int 1991; 49: 197-201.
35. Seno H, Oshima M, Ishikawa T O, Oshima H, Takaku K, Chiba T, et al. Cyclooxygenase 2-and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc(Delta716) mouse intestinal polyps. Cancer Res 2002; 62: 506-11.
36. Simmons D L, Botting R M, Hla T. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 2004; 56: 387-437.
37. Simon A M, Manigrasso M B, O'Connor J P. Cyclo-oxygenase 2 function is essential for bone fracture healing. J Bone Miner Res 2002; 17: 963-76.
38. Simon A M, O'Connor J P. Dose and time-dependent effects of cyclooxy-genase-2 inhibition on fracture-healing. J Bone Joint Surg (Am) 2007; 89: 500-11.
39. Smith P K, Krohn R I, Hermanson G T, Mallia A K, Gartner F H, Provenzano M D, et al. Measurement of protein using bicinchoninic acid. Anal Bio-chem 1985; 150: 76-85.
40. Smith C J, Zhang Y, Koboldt C M, Muhammad J, Zweifel B S, Shaffer A, et al. Pharmacological analysis of cyclooxygenase-1 in infammation. Proc Natl Acad Sci USA 1998; 95: 13313-8.
41. Steinhilber D. 5-Lipoxygenase: enzyme expression and regulation of activity Pharm Acta Helv 1994; 69: 3-14.
42. Tanaka M, Sakai A, Uchida S, Tanaka S, Nagashima M, Katayama T, et al. Prostaglandin E2 receptor (EP4) selective agonist (ONO-4819.CD) accel-erates bone repair of femoral cortex after drill-hole injury associated with local upregulation of bone turnover in mature rats. Bone 2004; 34: 940-8.
43. Traianedes K, Dallas M R, Garrett I R, Mundy G R, Bonewald L F. 5-Lipoxy-genase metabolites inhibit bone formation in vitro. Endocrinology 1998; 139: 3178-84.
44. Wientroub S, Wahl L M, Feuerstein N, Winter C C, Reddi A H. Changes in tissue concentration of prostaglandins during endochondral bone differen-tiation. Biochem Biophys Res Commun 1983; 117: 746-50.
45. Yu Y, Fan J, Chen X S, Wang D, Klein-Szanto A J, Campbell R L, et al. Genetic model of selective COX2 inhibition reveals novel heterodimer sig-naling. Nat Med 2006; 12: 699-704.
46. Yuan C, Rieke C J, Rimon G, Wingerd B A, Smith W L. Partnering between monomers of cyclooxygenase-2 homodimers. Proc Natl Acad Sci USA 2006; 103: 6142-7.
47. Zhang X, Schwarz E M, Young D A, Puzas J E, Rosier R N, O'Keefe R J. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 2002; 109: 1405-15.
48. Zhang X, Ziran N, Goater J J, Schwarz E M, Puzas J E, Rosier R N, et al. Primary murine limb bud mesenchymal cells in long-term culture com-plete chondrocyte differentiation: TGF-beta delays hypertrophy and PGE2 inhibits terminal differentiation. Bone 2004; 34: 809-17.